Please read before exploring Peptide Insights
Important: The information on this website is intended for educational and research purposes only.
Peptide Insights provides information about peptides based on published scientific research and clinical literature. This content is designed to help you understand the science, not to guide personal medical decisions.
By continuing, you confirm that you are accessing this information for educational purposes and understand that it does not constitute medical advice.
Ala-Glu-Asp-Gly tetrapeptide · Cartilage Bioregulator
A Russian peptide bioregulator studied for cartilage repair and joint health
Typical Dose
5-10 mg daily for 10 days
Route
Subcutaneous
Frequency
Once daily for 10-day course
Cycle
10-day course, 2x per year
Cartalax is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by the St. Petersburg Institute of Bioregulation and Gerontology. It is part of a family of short regulatory peptides studied for their tissue-specific effects. Cartalax is specifically researched for its effects on cartilage and connective tissue, with studies suggesting it may stimulate chondrocyte proliferation and promote collagen synthesis.
As a peptide bioregulator, Cartalax is thought to penetrate cell nuclei and interact with chromatin, influencing gene expression in a tissue-specific manner. Research suggests it promotes the synthesis of proteoglycans and collagen type II in chondrocytes, the cells responsible for maintaining cartilage matrix.
Typical Dose
5-10 mg daily for 10 days
Dose Range
5-10 mg/day
Frequency
Once daily for 10-day course
Route
Subcutaneous injection
Cycle Length
10-day course, 2x per year
CLINICAL NOTES
Standard bioregulator protocol: 10-day course, repeat every 6 months. Can be combined with BPC-157 for comprehensive joint recovery.
IMPORTANT DISCLAIMER
This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol. Individual responses vary and medical supervision is recommended.
Cartalax is a cartilage-targeting peptide. It pairs well with other joint and connective tissue peptides.
BPC-157 + Cartalax covers both soft tissue and cartilage repair for comprehensive joint healing.
TB-500's systemic healing effects complement Cartalax's cartilage-specific action.
GHK-Cu adds collagen synthesis to Cartalax's cartilage repair for complete connective tissue support.
Real experiences from the Peptide Insights community
Have experience with Cartalax?
Log in to share your experience and help the community.
No reviews yet for Cartalax
Be the first to share your experience.